Xiaomei Cai

Xiaomei’s practice encompasses all facets of complex patent litigation, including pre-suit investigation and counseling, discovery, claim construction and Markman hearings, trials, post-trial, injunction proceedings and appeals, before federal courts. She also represents clients in regulatory proceedings such as inter partes reviews before the Property Tax Appeal Board (PTAB), as well as in cross-border enforcement actions such as ITC Section 337 investigations. Xiaomei combines scientific acumen with a keen understanding of the legal issues that surround bringing new technology products and innovative services to the market.

She also has substantial experience handling China-related intellectual property matters and cross-border IP disputes spanning chemical, pharmaceutical, biotechnology and consumer electronics. For example, Xiaomei has:

• Represented a leading Chinese polymer manufacturer in an ITC 337 investigation
• Represented a biopharmaceutical company in a patent infringement action against online retailers of bioactive and small molecules compounds into the US
• Defending a China-based manufacturer of HDMI products in cross-border litigation involving claim of trade secret misappropriation
• Defending a China-based manufacturer of expresso machine products in a litigation involving claim of trademark infringement
• Advised a leading Chinese food and flavoring company relating to the analysis of patent noninfringement of equipment and processes for soy source manufacturing
• Counseled a Chinese pharmaceutical company relating to its defense against patent infringement claims in connection with its Abbreviated New Drug Application (ANDA) application